“Bimekizumab Impact on Pain in Moderate to Severe Hidradenitis Suppurativa: Week 16 Results from BE HEARD I & II”. SKIN The Journal of Cutaneous Medicine, vol. 8, no. 1, Jan. 2024, p. s350, https://doi.org/10.25251/skin.8.supp.350.